Table 3.
Parameter | Healthy n = 14 | No AKI n = 18 | AKI n = 36 | AKIN 1 n = 17 | AKIN 2 n = 15 | AKIN 3 n = 3 | |
ADC ×10−3 mm2/s | Cortex | 2.12 ± 0.04 | 2.05 ± 0.04 | 1.99 ± 0.03∗ | 1.97 ± 0.04∗ | 2.01 ± 0.05 | 1.99 ± 0.12 |
Medulla | 2.20 ± 0.03 | 2.18 ± 0.05 | 2.07 ± 0.02∗# | 2.06 ± 0.04∗# | 2.09 ± 0.04 | 2.06 ± 0.12 | |
FA | Cortex | 0.15 ± 0.01 | 0.14 ± 0.01 | 0.14 ± 0.004 | 0.14 ± 0.01 | 0.14 ± 0.01 | 0.12 ± 0.01 |
Medulla | 0.33 ± 0.02 | 0.28 ± 0.01∗∗ | 0.27 ± 0.01∗∗∗ | 0.27 ± 0.01∗∗ | 0.26 ± 0.01∗∗∗ | 0.27 ± 0.05∗ | |
ADCd | Cortex | 1.47 ± 0.04 | 1.44 ± 0.04 | 1.43 ± 0.02 | 1.41 ± 0.03 | 1.46 ± 0.03 | 1.40 ± 0.11 |
×10−3 mm2/s | Medulla | 1.57 ± 0.05 | 1.50 ± 0.04 | 1.49 ± 0.02 | 1.49 ± 0.03 | 1.52 ± 0.03 | 1.38 ± 0.13 |
ADCp | Cortex | 10.03 ± 0.44 | 9.89 ± 0.52 | 8.58 ± 0.26∗# | 8.25 ± 0.35∗# | 9.13 ± 0.43 | 8.09 ± 0.99 |
×10−3 mm2/s | Medulla | 9.89 ± 0.36 | 10.22 ± 0.47 | 9.31 ± 0.25 | 8.92 ± 0.25# | 9.78 ± 0.47 | 9.13 ± 1.26 |
Fp | Cortex | 0.36 ± 0.02 | 0.34 ± 0.02 | 0.31 ± 0.01∗ | 0.30 ± 0.01∗ | 0.32 ± 0.01 | 0.32 ± 0.06 |
Medulla | 0.35 ± 0.02 | 0.36 ± 0.02 | 0.33 ± 0.01 | 0.33 ± 0.01 | 0.32 ± 0.01 | 0.36 ± 0.01 |
Significant differences compared to healthy volunteers (∗P < .05, ∗∗P < .01, ∗∗∗P < .001) and patients without AKI (#P < .05) are indicated. No significant differences were found between groups of different AKI stages.
ADC = apparent diffusion coefficient, quantitative value of diffusion, ADCd = ADC diffusion, quantitative value of pure diffusion, ADCp = ADC perfusion, quantitative value of pseudodiffusion, AKI = acute kidney injury, AKIN 1-3 = AKI stage 1–3 according to the Acute Kidney Injury Network criteria corresponding to mild, moderate and severe AKI, FA = fractional anisotropy, quantitative value of diffusion anisotropy, Fp = perfusion fraction.